Overview Fundamentals API Earnings EOD API Sample Code Pricing

Gongwin Biopharm Holdings Co. Ltd. (6617 TWO) stock market data APIs

NT$139 3(2.2%) as of July 26, 2024
Price chart is built with Anychart

Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.

Gongwin Biopharm Holdings Co. Ltd. Financial Data Overview

136
139
-
139.5
136
126-246.5
0
0
0
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '6617',
Type: 'Common Stock',
Name: 'Gongwin Biopharm Holdings Co. Ltd.',
Exchange: 'TWO',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Gongwin Biopharm Holdings Co. Ltd. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Gongwin Biopharm Holdings Co. Ltd. Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Gongwin Biopharm Holdings Co. Ltd. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com